Related Experiment Video
Updated: Mar 28, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Treatment for hypoactive sexual desire.
1Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montréal, QC H4B 1R6, Canada.
Flibanserin targets serotonin receptors in the brain to modulate dopamine and noradrenaline levels. This mechanism is key to enhancing sexual desire in women.
Area of Science:
- Neuropharmacology
- Neuroscience
- Endocrinology
Background:
- Serotonin plays a complex role in regulating mood and sexual function.
- Dysregulation of monoamine neurotransmitters is implicated in hypoactive sexual desire disorder (HSDD).
Purpose of the Study:
- To elucidate the neuropharmacological mechanism of flibanserin in treating HSDD.
- To understand how flibanserin influences neurotransmitter systems critical for sexual desire.
Main Methods:
- Flibanserin's action on serotonin 5-HT1A autoreceptors and 5-HT2A receptors was investigated.
- The drug's impact on the turnover of dopamine and noradrenaline was assessed.
Main Results:
- Flibanserin inhibits serotonin release by binding to 5-HT1A autoreceptors.
- It also blocks postsynaptic serotonin action at 5-HT2A receptors.
- This leads to the disinhibition of dopamine and noradrenaline turnover.
Conclusions:
- Flibanserin's mechanism involves modulating serotonin to indirectly increase dopamine and noradrenaline.
- This neurochemical modulation is crucial for its therapeutic effect on sexual desire.
More Related Videos
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antidepressant Drugs: MAOIs and Other Agents
Psychosexual Stages of Personality: Genital
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

